- Shenzhen Antmed Co., Ltd.
- Main products: Angiographic syringe, SINGLE/ double pressure monitoring kit, DISPOSABLE PRESSURE TRANSDUCER, Medrad syringe, LF/ Mallinckrodt syringe, Inflation device, Contrast Media injector, Nemoto syringe, Medtron syringe, IBP transducer
Home > Company Introduction
Contact Supplier
sindy 8613377785917
sales represetativeYour inquiry content must be between 10 to 5000 characters
Please enter Your valid email address
Company Introduction
Shenzhen Antmed Co., Ltd.
-
Shenzhen, Guangdong, China
-
301 - 500 People
-
Angiographic syringe ,SINGLE/ double pressure monitoring kit , DISPOSABLE PRESSURE TRANSDUCER ,Medrad syringe ,LF/ Mallinckrodt syringe ,Inflation device ,Contrast Media injector ,Nemoto syringe ,Medtron syringe ,IBP transducer
-
North America, South America, Eastern Europe, Southeast Asia, Africa, Oceania
Business licenseTrade & Market
- North America , South America , Eastern Europe , Southeast Asia , Africa , Oceania , Mid East , Eastern Asia , Western Europe , Central America , Northern Europe , Southern Europe , South Asia , Domestic Market
Factory Information
- 10,000-30,000 square meters
- 18 Jinhui Ave., Pingshan New District,, Shenzhen, Guangdong
- 301 - 500 People
- 10-20 People
CE,ISO,FDA(510K)
Our Vision To be a globally respected company in the medical device industry. Our Mission Focus on cutting - edge product innovation in healthcare. Values To be an ethical & responsible business. that will value our employees and grow with our partners. Quality Policy Establish a customer - centric QMS to provide high-quality products and service.
March 2004 - Shenzhen Ant Hi-Tech the predecessor of the Company, was incorporated. July 2005 - The Company obtained the registration certificate for launching its CMPI high pressure syringes and pressure connecting tubes in China. April 2006 - The Company obtained the registration certificate for launching its CMPI in China. May 2008 - The Company obtained FDA510(k) Certificate issued by the FDA for its CMPI angiographic syringes. February 2009 - The Company obtained the registration certificate for launching its disposable pressure transducers in China. August 2009 - The Company obtained FDA510(k) Certificate issued by the FDA for its disposable pressure transducers. July 2011 - The Company obtained FDA510(k) Certificate issued by the FDA for its inflation devices and inflation device compact pack. 2011 - Annual revenue of the Company reached RMB100.0 million. May 2012 - The Company obtained the registration permission for its CMPI high pressure syringes to launch in Canada. September 2012 - The Company obtained a new National High-tech Enterprise Certificate. February 2014 - The Company obtained FDA510(k) Certificate issued by the FDA for its pressure connecting tubes. August 2014 - The Company obtained the registration certificate for launching its dental implant systems in China. . June 2015 - The Company obtained a new National High-tech Enterprise Certificate. July 2015 - The Company completed the construction of its research, development and production facility located in Pingshan New District, Shenzhen. 2017 - Annual revenue of the Company reached RMB300.0 million. February 2018 - Shenzhen Ant Hi-Tech Industrial Co., Ltd. is now a joint stock limited company under the new name Shenzhen Antmed Co., Ltd.
